Language

CAS No. 1239908-20-3 | Ixazomib citrate (USAN)

CAS No. 1239908-20-3 | Ixazomib citrate (USAN)

Name: Ixazomib citrate (USAN) CAS No.1239908-20-3 MF:C20H23BCl2N2O9 MW:517.12 Purity:98% Package: 10mg,25mg,50mg,100mg,250mg Worldwide Delivery

Categories：

Biochemicals

Email：sale06@alfachem.cn

Inquiry

Chat Now

Product introduction

Introduction and application of CAS No. 1239908-20-3 | Ixazomib citrate (USAN)

Synonyms:2-[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diaceticacid;

2,2'-(2-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diaceticacid;

IXAZOMIBCITRATE;

(R)-2,2'-(2-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diaceticacid;

2-[4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]aceticacid

Specification:

ITEMS	SPECIFICATION
CAS	1239908-20-3
MF	C20H23BCl2N2O9
MW	517.12
Density	1.47±0.1 g/cm3
Acidity coefficient	3.59±0.10
Solubility	DMSO: 100.0 (maximum concentration mg/mL);
Storage condition	Store at -20°C

Indications:

Isazomib is a proteosome inhibitor indicated for use in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.

Package and transportation :

Package: 10mg,25mg,50mg,100mg,250mg